[Etoposide, pirarubicin and cisplatin(ETP) combined therapy of inoperable head and neck cancer].
Kawakami
T
T
Dept. of Otolaryngology, Okayama University Medical School.
Watanabe
S
S
Ogawara
T
T
Akagi
S
S
Tamura
S
S
Koide
I
I
Ogawa
A
A
Takiguchi
S
S
Masuda
Y
Y
D000230:Adenocarcinoma / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged
D000903:Antibiotics, Antineoplastic; D005047:Etoposide; D004317:Doxorubicin; C027260:pirarubicin; D002945:Cisplatin